Cover Image

Breast Cancer Interaction Network Concept from Mostly Related Components

Mostafa Rezaei-Tavirani, Mona Zamanian Azodi, Davood Bashash, Naybali Ahmadi, Mohammad Rostaim-Nejad
Background: Management of breast cancer (BC) as a heterogeneous disease is very challenging. Biomarker discovery has been shown promising for this aim. Protein interaction mapping could provide further knowledge of the vital roles of these markers. Materials and Methods: Cytoscape and its plug-ins are used for network construction and evaluation. The plug-ins used in this study are STRING, Network Analyzer, GeneMANIA, and CluePedia. Results: The central proteins are enriched in transcription regulatory region DNA binding, regulatory region nucleic acid binding, regulatory region DNA binding, Fc receptor signaling pathway, cell cycle arrest, and immune response-regulating cell surface receptor signaling pathway. Conclusion: The introduced biomarkers and their related biological processes may show useful for the breast cancer diagnosis and monitoring; however, has to encounter more validation studies to be clinically applicable. [GMJ.2019;8:e1298]

 

Porto-Mascarenhas EC, Assad DX, Chardin H, Gozal D, Canto GDL, Acevedo AC et al. Salivary biomarkers in the diagnosis of breast cancer: A review. Critical reviews in oncology/hematology. Crit Rev Oncol Hematol. 2017;110:62-73.

https://doi.org/10.1016/j.critrevonc.2016.12.009

PMid:28109406

Halakou F, Gursoy A, Kilic ES, Keskin O, editors. Topological, functional, and structural analyses of protein-protein interaction networks of breast cancer lung and brain metastases. Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), 2017 IEEE Conference on. 2017.

https://doi.org/10.1109/CIBCB.2017.8058539

Aslebagh R, Channaveerappa D, Arcaro KF, Darie CC. Proteomics analysis of human breast milk to assess breast cancer risk. Electrophoresis. 20187;. 39(4):653-665.

https://doi.org/10.1002/elps.201700123

PMid:29193311

Rezaei-Tavirani M, Rezaei-Tavirani S, Mansouri V, Rostami-Nejad M, Rezaei-Tavirani M. Protein-Protein Interaction Network Analysis for a Biomarker Panel Related to Human Esophageal Adenocarcinoma. Asian Pacific Journal of Cancer Prevention Asian Pac J Cancer Prev. 2017;18(12):3357-63.

Tyanova S, Albrechtsen R, Kronqvist P, Cox J, Mann M, Geiger T. Proteomic maps of breast cancer subtypes. Nature communications Nat Commun. 2016;10259 (7):1-11.

https://doi.org/10.1038/ncomms10259

PMid:26725330 PMCid:PMC4725767

Valizadeh R, Monfared AB, Rezaei-Tavirani M, Mansouri V. Evaluation of involved proteins in colon adenocarcinoma: an interactome analysis. Gastroenterology and Hepatology from bed to bench Gastroenterol Hepatol Bed Bench. 2017;10(1) 129-138.

Barabasi A-L, Oltvai ZN. Network biology: understanding the cell's functional organization. Nature reviews genetics Nat Rev Genet. 2004;5(2):101-113.

https://doi.org/10.1038/nrg1272

PMid:14735121

Dashatan NA, Tavirani MR, Zali H, Koushki M, Ahmadi N. Prediction of Leishmania Major Key Proteins via Topological Analysis of Protein-Protein Interaction Network. Galen Medical Journal Galen. 2018;7:1-11.

Abdolahi H, Azodi MZ. Protein interaction mapping interpretation of none alcoholic fatty liver disease model of rats after fat diet feeding. Gastroenterology and Hepatology from bed to bench Gastroenterol Hepatol Bed Bench. 2017;10(1):146-153.

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome researchGenome Res. 2003;13(11):2498-504.

https://doi.org/10.1101/gr.1239303

PMid:14597658 PMCid:PMC403769

Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic acids research Nucleic Acids Res. 2016; 45:362-368.

https://doi.org/10.1093/nar/gkw937

PMid:27924014 PMCid:PMC5210637

Montojo J, Zuberi K, Rodriguez H, Kazi F, Wright G, Donaldson SL et al. GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics. 2010;26(22):2927-8.

https://doi.org/10.1093/bioinformatics/btq562

PMid:20926419 PMCid:PMC2971582

Bindea G, Galon J, Mlecnik B. CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics. 2013;29(5):661-3.

https://doi.org/10.1093/bioinformatics/btt019

PMid:23325622 PMCid:PMC3582273

Giunti G, Giunta D, Guisado-Fernandez E, Bender J, Fernandez-Luque L. A biopsy of Breast Cancer mobile applications: state of the practice review. International journal of medical informatics Int J Med Inform. 2018;110:1-9.

https://doi.org/10.1016/j.ijmedinf.2017.10.022

PMid:29331247

Beretov J, Wasinger VC, Millar EK, Schwartz P, Graham PH, Li Y. Proteomic analysis of urine to identify breast cancer biomarker candidates using a label-free LC-MS/MS approach. PloS one PLoS One. 2015;10(11): 1-20.

https://doi.org/10.1371/journal.pone.0141876

PMid:26544852 PMCid:PMC4636393

Tomas A, Futter CE, Eden ER. EGF receptor trafficking: consequences for signaling and cancer. Trends in cell biology Trends Cell Biol. 2014;24(1):26-34.

https://doi.org/10.1016/j.tcb.2013.11.002

PMid:24295852 PMCid:PMC3884125

Petitjean A, Achatz M, Borresen-Dale A, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene. 2007;26(15): 2157-65.

https://doi.org/10.1038/sj.onc.1210302

PMid:17401424

Stahl P, Seeschaaf C, Lebok P, Kutup A, Bockhorn M, Izbicki JR et al. Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer. BMC Gastroenterol BMC Gastroenterol. 2015;15(7). 231-4.

https://doi.org/10.1186/s12876-015-0231-4

PMid:25649416 PMCid:PMC4324419

Therkildsen C, Bergmann TK, Henrichsen-Schnack T, Ladelund S, Nilbert M. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis. Acta oncologica Acta Oncol. 2014;53(7):852-64.

https://doi.org/10.3109/0284186X.2014.895036

PMid:24666267

Shachaf CM, Kopelman AM, Arvanitis C, Karlsson Å, Beer S, Mandl S et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature. 2004;431(7012): 1112-7.

https://doi.org/10.1038/nature03043

PMid:15475948

Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer research. 2004;64(21):7678-81.

https://doi.org/10.1158/0008-5472.CAN-04-2933

PMid:15520168

Soleimani Z, Kheirkhah D, Sharif MR, Sharif A, Karimian M, Aftabi Y. Association of CCND1 Gene c. 870G> A polymorphism with breast cancer risk: A case-controlstudy and a meta-analysis. Pathology & Oncology Research Pathol Oncol Res. 2017;23(3):621-31.

https://doi.org/10.1007/s12253-016-0165-3

PMid:28004353

Garcia R, Franklin RA, McCubrey JA. EGF induces cell motility and multi-drug resistance gene expression in breast cancer cells. Cell Cycle. 2006;5(23):2820-6.

https://doi.org/10.4161/cc.5.23.3535

PMid:17172846

Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proceedings of the National Academy of Sciences. Proc Natl Acad Sci U S A2003;100(20):11606-11.

https://doi.org/10.1073/pnas.1933744100

PMid:14500907 PMCid:PMC208805

Perou CM, Jeffrey SS, Van De Rijn M, Rees CA, Eisen MB, Ross DT et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proceedings of the National Academy of Sciences Proc Natl Acad Sci U S A. 1999;96(16):9212-7.

https://doi.org/10.1073/pnas.96.16.9212

PMid:10430922 PMCid:PMC17759

Gu Y, Zhang S, Wu Q, Xu S, Cui Y, Yang Z et al. Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer. Journal of Experimental & Clinical Cancer Research. J Exp Clin Cancer Res. 2010;29(6):1-10.

https://doi.org/10.1186/1756-9966-29-6

PMid:20092659 PMCid:PMC2845556

Brooks D, Ravetch JV. Fc receptor signaling. Mechanisms of Lymphocyte Activation and Immune Regulation V. Springer. 1994; 365:185-95.

https://doi.org/10.1007/978-1-4899-0987-9_19

PMid:7887303

Schmidt M, Böhm D, Von Törne C, Steiner E, Puhl A, Pilch H et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer research. 2008;68(13):5405-13.

https://doi.org/10.1158/0008-5472.CAN-07-5206

PMid:18593943

Janes PW, Daly RJ, Sutherland R. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene. 1994;9(12):3601-8.

De Boer C, Kluin-Nelemans J, Dreef E, Kester M, Kluin P, Schuuring E et al. Involvement of the CCND1 gene in hairy cell leukemia. Annals of Oncology Ann Oncol. 1996;7(3):251-5.

https://doi.org/10.1093/oxfordjournals.annonc.a010568

PMid:8740788

Bièche I, Laurendeau I, Tozlu S, Olivi M, Vidaud D, Lidereau R et al. Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer research. 1999;59(12):2759-65.

Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. JNCI: Journal of the National Cancer Institute J Natl Cancer Inst. 1993;85(3):200-6.

https://doi.org/10.1093/jnci/85.3.200

PMid:8423624

Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al. High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004;304(5670):554.

https://doi.org/10.1126/science.1096502

PMid:15016963

Refbacks

  • There are currently no refbacks.